CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
151 hedge funds and large institutions have $1.02B invested in Cymabay Therapeutics in 2023 Q2 according to their latest regulatory filings, with 45 funds opening new positions, 42 increasing their positions, 39 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
8% more repeat investments, than reductions
Existing positions increased: 42 | Existing positions reduced: 39
10% less funds holding in top 10
Funds holding in top 10: 10 → 9 (-1)
Holders
151
Holding in Top 10
9
Calls
$3.85M
Puts
$225K
Top Buyers
| 1 | +$53.2M | |
| 2 | +$27.7M | |
| 3 | +$21.9M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$18M |
| 5 |
Jennison Associates
New York
|
+$11.5M |
Top Sellers
| 1 | -$26.6M | |
| 2 | -$18.7M | |
| 3 | -$16.5M | |
| 4 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$13.5M |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$11.7M |